Evaluation of XTR004 as a Novel 18F-labeled PET MPI Tracer in Diagnosis of Known or Suspected CAD
Status:
Completed
Trial end date:
2023-05-09
Target enrollment:
Participant gender:
Summary
The diagnostic efficacy and safety of the XTR004 myocardial perfusion PET imaging tracer are
evaluated for known or suspected CAD with the use of invasive coronary angiography as the
reference standard for the diagnosis of CAD and invasive pressure-temperature FFR/IMR as a
reference for the detection of abnormal coronary function.